Advertisement
Screener

INTERLEUKIN GENETICS INC Revenue Recognition, Milestone Method, Revenue Recognized

INTERLEUKIN GENETICS INC Revenue Recognition, Milestone Method, Revenue Recognized

INTERLEUKIN GENETICS INC reported Revenue Recognition, Milestone Method, Revenue Recognized of $141.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-11.

Discontinued › Notes › Revenue Recognition and Deferred Revenue

us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized · last filed 2017-05-11

  • INTERLEUKIN GENETICS INC revenue recognition, milestone method, revenue recognized for the quarter ending 2017-03-31 was $141.00K, a 46.18% decline year-over-year.
  • INTERLEUKIN GENETICS INC revenue recognition, milestone method, revenue recognized for the quarter ending 2016-03-31 was $262.00K, a 24.71% decline year-over-year.
  • INTERLEUKIN GENETICS INC revenue recognition, milestone method, revenue recognized for the quarter ending 2015-03-31 was $348.00K.
Period endRevenue Recognition, Milestone Method, Revenue Recognized 3 monthRevenue Recognition, Milestone Method, Revenue Recognized 6 monthRevenue Recognition, Milestone Method, Revenue Recognized 9 month
2017-03-31$141.00K
10-Q · filed 2017-05-11
2016-09-30$881.00K
10-Q · filed 2016-11-14
2016-06-30$612.00K
10-Q · filed 2016-08-15
2016-03-31$262.00K
10-Q · filed 2017-05-11
2015-09-30$922.00K
10-Q · filed 2016-11-14
2015-06-30$673.00K
10-Q · filed 2016-08-15
2015-03-31$348.00K
10-Q · filed 2016-05-12